A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: The P3BEP Trial (ANZUP 1302) (#266)

3:00 PM

Howard Chan

Posters1

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate  cancer: ENZARAD (ANZUP 1303) (#273)

3:00 PM

Scott G Williams

Posters1

Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: the ANZUP ENZAMET Trial (ANZUP 1304) (#269)

3:00 PM

Ian Davis

Posters1

Randomised phase 3 double-blind placebo-controlled trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasound-guided prostate biopsy (Pain-Free TRUS B): ANZUP 1501 (#270)

3:00 PM

Ian Davis

Posters1

Randomised phase 3 trial of the addition of Mitomycin  to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer(ANZUP 1301) (#267)

3:00 PM

Howard Chan

Posters1

Timing and patterns of referral to palliative care for patients with metastatic non-small cell lung cancer (NSCLC) in South Western Sydney Local Health District (SWSLHD). (#151)

3:15 PM

Peey-Sei Kok

Best of the Best Posters - Clinical & Health services research